Revised Intimation (including the Resignation Letter) of Resignation of Non Executive Non Independent Director in terms of SEBI(LODR) Regulation, 2015
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mr. Suraj Chagan Solanki (DIN: 10380845) has tendered his resignation as Non-Executive Non-Independent Director of Welcure Drugs & Pharmaceuticals Ltd, effective from the close of business hours on 06th August 2025. The reason cited is pre-occupation, meaning he is unable to devote sufficient time to the company's affairs. Mr. Solanki has confirmed there are no other material reasons behind his resignation. The Board of Directors has noted the resignation and placed on record its appreciation for his contribution during his tenure. The Managing Director and CFO, Mr. Chintan Didawala Ganpat (DIN: 11088268), continues in his role, as evident from his signing the filing.
This is a routine board-level change with no operational or financial implications. The company's management team, including the MD and CFO, remains unchanged, so day-to-day business and governance continuity are unaffected.